Loading…
DMRA
Damora Therapeutics, Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 36322Q206
$18.44-1.60%Price as of Oct 17, 12:03 UTC · updated once a day, after the close
At a glance
Damora Therapeutics, Inc. (DMRA) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Waltham, United States and has 7 employees. The company is worth $1.14B. The share price is 51.9% below its 52-week high of $38.33. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Andreas Halvorsen (Viking Global Investors), at $60.11M. In that quarter, 1 of them opened or added to the position and 1 reduced it. Over the last 30 days, company insiders bought $252.88K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $1.14B
- P/E
- —
- Forward P/E
- —
- P/B
- 2.9x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.25
- ROE
- -99.74%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 1.44
- 52-week high
- $38.33
- 52-week low
- $4.95
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -73.8% over 5Y.
today you would have $223.52▼ -77.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 6 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $23.01 | $4.65 | $18.00 | $28.75 | $75.75 | $312.75 | |
| P/E | — | 5.8x | — | — | — | — | — |
| P/B | 0.6x | 5.8x | 0.4x | 0.6x | 0.5x | 0.7x | 1.9x |
| EPS | $3.98 | -$18.53 | -$36.08 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | $20.03 | — | 3.4x | 0.00% | -30.24% | $1.14B |
| DRTSAlpha Tau Medical Ltd. | $12.29 | — | 25.8x | 0.00% | -141.68% | $1.14B |
| REPLReplimune Group, Inc. | $11.99 | — | 9.5x | 0.00% | -134.29% | $1.13B |
| IMTXImmatics N.V. | $7.54 |
About the company
- 7
- Waltham, United States